Article, see p 850 I n this issue of Circulation, Mariscalco and colleagues 1 report findings from 2 separate analyses that describe lower in-hospital mortality rates in overweight and obese (class I and class II) patients undergoing cardiac surgery in comparison with leaner patients. Obesity paradoxes are not new to the field of cardiovascular disease and have been observed in heart failure, 2 acute coronary syndromes, 3 and chronic kidney disease. 4 Rather, the novelty of the present study is the authors' interpretation that the common practice of recommending weight loss before surgery may not be warranted, and that refusing surgery to patients who are morbidly obese should be reconsidered. Although such strong clinical recommendations contradict the extensive body of research describing the risk of significant perioperative complications for obese patients undergoing any type of surgery, the methodologies they used to generate their findings are appropriate and the provocative findings warrant continued discussion.
surgical candidates, furthering the potential for selection bias as an explanation for the observed obesity paradox in an observational study.
The primary reason that the findings from this study are consistent with the existing body of research describing an obesity paradox is the biological plausibility of a paradox within the selected patient population with significant comorbid disease. Obesity predisposes to mortality through 2 pathways, overnutrition and undernutrition. 5 The consequences of overnutrition are seen in long-term mortality. Excess energy intake leads to adiposity and an adverse metabolic cascade that includes high cholesterol, elevated blood glucose, and high blood pressure, which in turn results in a higher burden of cardiovascular disease that develops over decades. By contrast, undernutrition, which may be a consequence of slow progressive wasting or acute wasting is reflected by leaner body habitus and predisposes to higher shortterm mortality. In the current study, body mass index was assessed at the time of surgery and does not account for unintentional weight loss before the procedure, which may be associated with critical illness, frailty, and comorbidities, even in the absence of cachexia or malnutrition. When the outcome under study is in-hospital (cohort study) and 30-day mortality (meta-analysis) following cardiac surgery, it is clearly an acute phase of chronic disease.
Determining causality based on epidemiological studies, no matter how well designed, has limitations. Criticisms of the obesity paradox are warranted for a number or reasons that have been previously described (eg, selection bias, reverse causation, residual confounding) 6 ; many of these limitations are addressed by the authors. However, the contribution of selection bias to the findings may be understated by the authors. Commonly used multivariable risk models have been developed to predict mortality in the setting of cardiac surgery and facilitate informed consent and timing and choice of surgical intervention, such as the EuroSCORE II study (European System for Cardiac Operative Risk Evaluation) and the STS models (Society for Thoracic Surgeons 2008 Cardiac Surgery Risk Models). Use of these scores may have resulted in a more homogenous risk profile of patients selected for cardiac surgery across all body mass index groups. It is important to note that body mass index is not included in the EuroSCORE II, because the relationship between body mass index and mortality risk was very weak in the derivation of the model, suggesting that weight itself is not an important contributor toward outcomes when weight-related comorbidities are taken into account (eg, diabetes mellitus, renal dysfunction). 7 An additional limitation that warrants emphasis is that epidemiological studies are unable to explain why heavier weight is associated with better short-term outcomes in patients undergoing cardiac surgery. Relying on anthropometric measures to estimate adiposity rather than detailed assessment of body composition and body fat distribution using noninvasive (ie, imaging) and invasive (ie, fat and muscle biopsies) prohibits insight into etiology. For example, muscle quality and function, which could be measured using imaging, biopsies, and functional tests, can be used to determine sarcopenia. Sarcopenia is associated with elevated risks for metabolic disorders, functional decline, and frailty, each of which contribute to long-and short-term mortality. 8 Measurement of proinflammatory adipocytokines expressed and secreted by adipose tissue, such as plasminogen activator inhibitor-1, which closely correlates with visceral fat area and has been associated with cardiovascular outcomes, may offer utility for additional risk stratification preoperatively. 9 What is equally important to patients and their families, but not assessed in this study, is medium-and longterm morbidity. The postoperative complications considered here, deep sternal wound infections and renal replacement therapy, interfere with quality of life and ultimately with mortality. For these reasons, it is not clear that a paradox would have been observed had mortality been extended to 1 year or 5 years.
In summary, this well-designed study highlights a critical knowledge gap in cardiac surgical guidelines regarding perioperative weight management before cardiac surgery. In particular, obese class II patients had a nearly 5 times greater risk for deep sternal wound infection and a 25% higher likelihood of needing renal replacement therapy. Even if surgery is determined to be beneficial in these patients, additional intervention in the perioperative period that may include weight loss recommendations should be considered, and postoperative surveillance for complications should be enhanced. Based on these factors, a more cautious final recommendation may be for future studies to prospectively assess weight-loss interventions before elective surgery in the context of overall surgical risk as assessed by the EuroScore and STS models. 
FOOTNOTES
Circulation is available at http://circ.ahajournals.org.
